Premium
PEG2000‐DPSE‐coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells
Author(s) -
Wang Gang,
Wang JunJie,
Luo Jie,
Wang Lei,
Chen XuanLi,
Zhang LiPing,
Jiang ShanQing
Publication year - 2013
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.34607
Subject(s) - materials science , quercetin , glioma , nanoparticle , programmed cell death , nanotechnology , cancer research , apoptosis , biology , biochemistry , antioxidant
In this study, PEGylated nanoparticles quercetin drug delivery vehicles were investigated as carriers for anticancer drugs induced programed cell death (PCD). PEG2000‐DPSE‐coated quercetin nanoparticles were prepared and tumor cell killing efficacy was studied on glioma C6 cells and assayed for cell survival, apoptosis, or necrosis. The levels of ROS production and mitochondrial membrane potential (ΔΨ m ) were determined. Western blot assayed p53, p‐p53, cytochrome C, and caspase proteins expression were also studied. Results indicate that PEG2000‐DPSE‐QUE‐NPS showed dose‐dependent cytotoxicity to C6 glioma cells and enhanced ROS accumulation induced upregulation of p53 protein, which was accompanied with an increase in cytochrome c and caspase‐3 protein levels. These results support the hypothesis that quercetin nanoparticles‐coated PEG2000‐DPSE remarkably enhanced anticancer effect of induced programed cell death on C6 glioma cells. Overall, PEG2000‐DPSE‐coated quercetin nanoparticles showed promising potential as a drug carrier for cancer therapy. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3076–3085, 2013.